Corrigendum to “1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor” [Bioorg. Med. Chem. 16 (2008) 2852–2869]

Bioorganic & Medicinal Chemistry 16 (2008) 8766

Contents lists available at ScienceDirect

Bioorganic & Medicinal Chemistry journal homepage: www.elsevier.com/locate/bmc

Corrigendum

Corrigendum to ‘‘1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor” [Bioorg. Med. Chem. 16 (2008) 2852–2869] Angela Stefanachi a, Jose Manuel Brea c, Maria Isabel Cadavid c, Nuria B. Centeno d, Cristina Esteve e, Maria Isabel Loza c, Ana Martinez b, Rosa Nieto b, Enrique Raviña b, Ferran Sanz d, Victor Segarra e, Eddy Sotelo b, Bernat Vidal e, Angelo Carotti a,* a

Dipartimento Farmaco-chimico, Università di Bari, via Orabona 4, I-70125 Bari, Italy Departamento de Quimica Organica, Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain c Departamento de Farmacologia, Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain d Unitat de Recerca en Informàtica Biomèdica (GRIB), IMIM-UPF, C/Dr. Aiguader 80, E-08003 Barcelona, Spain e Almirall Research Center, Laboratorios Almirall S.A., Ctra. Laureà Miró 408, E-08980 St. Feliu de Llobregat, Barcelona, Spain b

The following items should be corrected: In Tables 1, 2, and 3, the heading of the second column should read R3/R1 and not R1/R3. On page 2858, for Compound 58, the second column should read CH3/(CH3)2CHCH2 and not (CH3)2CHCH2/Pr. On page 2861, for Compound 87, the second column should read Pr/CH3 and not CH3/Pr.

DOI of original article: 10.1016/j.bmc.2008.01.002 * Corresponding author. Tel.: +39 080 5442782; fax: +39 080 5442230. E-mail address: [email protected] (A. Carotti). 0968-0896/$ - see front matter Ó 2008 Elsevier Ltd. All rights reserved. doi:10.1016/j.bmc.2008.08.044